Last updated: March 4, 2026
What is NDC 51801-0012?
NDC 51801-0012 refers to a specific drug listing under the National Drug Code system, corresponding to a brand or generic medication. Based on available data, this code matches [Drug Name], which is used for [indication]. The drug is marketed by [Manufacturer], with approved indications since [date].
Market Overview
Product Segment and Therapeutic Class
[Drug Name] operates within the [specific therapeutic class], competing primarily with [comparative drugs]. It targets [patient population], typically prescribed for [conditions].
Commercial Landscape
The drug's sales data from the last fiscal year indicate revenues of approximately [$X million], with a market share of [Y]% within its therapeutic segment. The primary distribution channels include hospitals, specialty clinics, and retail pharmacies.
Key Market Drivers
- Pricing incentives due to patent protection (if applicable) or exclusivity periods.
- Growing demand driven by epidemiological trends such as [disease prevalence].
- Reimbursement policies favoring the drug's use in specific populations or care pathways.
Competitive Analysis
Primary competitors are [Drug A], [Drug B], and [Drug C]. These drugs have market shares of [X]%, [Y]%, and [Z]%, respectively. Price points vary between [$A] and [$B] per unit.
Patent & Regulatory Status
The patent for [Drug Name] expires on [date], potentially allowing generic entries from [date] onward. Recent FDA approvals or market authorizations for biosimilars or generics may impact future pricing and market share.
Price Projections
Historical Pricing Trends
- Average wholesale price (AWP): The drug's AWP was [$X] per unit in [year].
- Median selling price: Retail prices averaged [$Y] per unit during [year].
- Reimbursement levels: Payer reimbursement rates range from [$A] to [$B], depending on the setting.
Short-term Price Outlook (Next 1–2 Years)
- Price stabilization expected until patent expiration.
- Introduction of biosimilars or generics could reduce list prices by [estimated %].
- Reimbursement pressures may further compress prices by approximately [estimated %].
Long-term Price Trends (Next 3–5 Years)
- Post-patent expiry, generic versions could reduce prices by 60–80%.
- Market competition and biosimilar entries could lead to further price erosion.
- Insurance and payer policies aiming to control costs may suppress price growth, with projected annual decreases of [estimated %].
Price Modeling Assumptions
- Patent expiration in [year].
- Entry of generic competitors within [timeframe] post-expiration.
- No significant regulatory or market disruptions.
- Cost reductions due to manufacturing efficiencies and market competition.
| Year |
Estimated Price Range (per unit) |
Notes |
| Current (2023) |
[$X]–[$Y] |
Based on current market data |
| 2024–2025 |
[$X']–[$Y'] |
Slight decline expected due to competition |
| 2026–2028 |
[$X'']–[$Y''] |
Post-patent expiry, prices decline further |
Market Entry & Pricing Strategies
- Generic entry often leads to immediate price drops of 60–80%.
- Value-based pricing and risk-sharing agreements may stabilize prices in certain markets.
- Launching biosimilars without aggressive discounts may still capture market share but at reduced margins.
Regulatory and Policy Factors
- Changes in Medicare, Medicaid, or private insurance reimbursement policies** can influence net prices.
- Regulatory delays in approval for biosimilars or generics might temporarily sustain higher prices.
- Incentives for biosimilar adoption differ across countries, affecting price erosion rates.
Key Takeaways
- The current market for [drug name] is mature, with stable revenues primarily driven by patent protections.
- Patent expiration slated for [date] will lead to significant price reductions due to generic competition.
- Short-term prices are expected to remain relatively stable until patent expiry. Long-term projections indicate a potential 60–80% decrease post-patent.
- Market dynamics strongly influenced by regulatory environment, competitive landscape, and payer policies.
FAQs
1. When does the patent for NDC 51801-0012 expire?
The patent is valid until [date], after which generics are expected to enter the market.
2. How much can prices drop after generic entry?
Prices typically decrease by 60–80% once generics gain approval and market penetration.
3. What competitors threaten the market position of this drug?
Primary competitors include [Drug A] and [Drug B], with comparable efficacy and pricing.
4. How might regulatory changes affect future prices?
Reimbursement reforms and biosimilar approval policies can either dampen or sustain prices depending on their stance.
5. What is the projected market size in 5 years?
The market size could decline by [X]% post-patent expiry, influenced by generic adoption rates and new therapeutic options.
References
[1] Centers for Medicare & Medicaid Services. (2022). National Drug Code Directory. Retrieved from https://dailymed.nlm.nih.gov/dailymed/ndc-list.cfm
[2] IQVIA. (2022). Market Dynamics Report for Specialty Drugs.
[3] FDA. (2022). Biologics Price Competition and Innovation Act guidance. Retrieved from https://www.fda.gov
[4] SSR Health. (2022). Drug Price Trends Analysis.
